Tenders/SECTION 1 Provision of services for the detection of antibodies against antigens

Open🇬🇷GreeceServices

SECTION 1 Provision of services for the detection of antibodies against antigens

Auto-translated from Greek

Original title: ΤΜΗΜΑ 1 Παροχή υπηρεσιών για την ανίχνευση αντισωμάτων έναντι των αντιγόνων

ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ

Published: Sep 27, 2026

Updated: Sep 27, 2026

Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a services contract in the health and medical services and energy and power sectors, with a focus on Nuclear. Located in Greece, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: Greek

Παροχή υπηρεσιών για την ανίχνευση αντισωμάτων έναντι των αντιγόνων: LGI1, CASPR2, NMDA receptor, AMPA receptors (GluR1, GluR2) GABAB receptors, GAD65, Hu (neurone nuclei; ANNA-1), Ri (neurone nuclei; ANNA-2), Yo (Purkinje cell cytoplasm; PCA-1) Amphiphysin, CV2 (CRMP-5), Ma1/Ma2 (neurone nucleoli; Ta), ANNA-3, PCA-2 (Purkinje cell cytoplasm), Tr (DNER), ZIC4, IgLON5, AGNA (anti-glia nuclear antigen),Recoverin Aquaporin-4, MOG (myelin-oligodendrocyte glycoprotein), Glycin receptors, DPPX, ITPR1 CARPVIII, Flotillin ½, mGluR1, mGluR5, Myelin MBP (myelin-basic protein), MAG (myelin-associated glycoprotein), GFAP (glial fibrillary acidic protein), Basal ganglia AT1A3, Contactin1, Dop. rec. 2 (DRD2), ERC1, GABA-a receptors, GluRD2, Homer3 KCNA2, Neurexin, Neurochondrin, Neurofascin (NF155/NF186), RhoGTpase-activating protein 26

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on September 27, 2026. Last refreshed today. Original language: Greek. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ

ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ has issued 40 procurement notices on BidsFactory, including 1 currently open and 1 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Information & Communication Technology. All notices are published for Greece. Notices are distributed via KIMDIS Greece and TED - Tenders Electronic Daily (EU). Most recent publication: September 27, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ in Greece. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Services contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Greece. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.